Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1700 of 2051 entries
View as:

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Phase: N/A Priority: Normal
NCT ID: NCT02252016 Org: User:
Start: 10/22/14 End: 06/14/16 Due: 06/14/17

ProQuad Dose Selection Study (V221-011)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00986232 Org: User:
Start: 04/30/99 End: 09/30/00 Due: 09/30/01

Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423)

Phase: N/A Priority: Normal
NCT ID: NCT00724893 Org: User:
Start: 08/31/05 End: 08/31/12 Due: 08/31/13

Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)

Phase: N/A Priority: Normal
NCT ID: NCT01011725 Org: User:
Start: 11/30/05 End: 03/31/09 Due: 03/31/10

Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)

Phase: N/A Priority: Normal
NCT ID: NCT00845000 Org: User:
Start: 04/21/09 End: 05/14/10 Due: 05/14/11

MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)

Phase: N/A Priority: Normal
NCT ID: NCT00302471 Org: User:
Start: 03/31/06 End: 10/31/07 Due: 10/31/08

Remicade® Crohn's Disease Registry Across Canada (Study P02793)

Phase: N/A Priority: Normal
NCT ID: NCT00755937 Org: User:
Start: 02/28/02 End: 09/30/07 Due: 09/30/08

A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)

Phase: N/A Priority: Normal
NCT ID: NCT00127192 Org: User:
Start: 07/31/05 End: 03/31/06 Due: 03/31/07

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00818272 Org: User:
Start: 12/31/02 End: 12/31/10 Due: 12/31/11

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Phase: N/A Priority: Normal
NCT ID: NCT00496327 Org: User:
Start: 06/22/05 End: 10/06/05 Due: 10/06/06

Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00086125 Org: User:
Start: 06/30/04 End: 06/30/06 Due: 06/30/07

Biomarkers of Muscle Anabolism (MK-0000-082)

Phase: N/A Priority: Normal
NCT ID: NCT00812396 Org: User:
Start: 11/30/07 End: 02/29/08 Due: 02/28/09

Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)

Phase: N/A Priority: Normal
NCT ID: NCT00485758 Org: User:
Start: 07/31/07 End: 08/31/08 Due: 08/31/09

Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)

Phase: N/A Priority: Normal
NCT ID: NCT01092780 Org: User:
Start: 05/26/10 End: 05/31/11 Due: 05/31/12

Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)

Phase: N/A Priority: Normal
NCT ID: NCT01479764 Org: User:
Start: 12/02/11 End: 11/05/12 Due: 11/05/13

A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)

Phase: N/A Priority: Normal
NCT ID: NCT00692614 Org: User:
Start: 06/30/08 End: 11/30/08 Due: 11/30/09

A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

Phase: N/A Priority: Normal
NCT ID: NCT06662396 Org: User:
Start: 06/13/24 End: 09/27/24 Due: 09/27/25

Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

Phase: N/A Priority: Normal
NCT ID: NCT00771316 Org: User:
Start: 12/31/08 End: 06/30/09 Due: 06/30/10

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

Phase: N/A Priority: Normal
NCT ID: NCT06045507 Org: User:
Start: 11/08/23 End: 02/12/25 Due: 02/12/26

Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00534794 Org: User:
Start: 10/31/07 End: - Due: -

Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)

Phase: N/A Priority: Normal
NCT ID: NCT00794898 Org: User:
Start: 07/01/03 End: 04/01/04 Due: 04/01/05

A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Phase: N/A Priority: Normal
NCT ID: NCT01698775 Org: User:
Start: 10/02/12 End: 01/19/16 Due: 01/19/17

A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Phase: N/A Priority: Normal
NCT ID: NCT05763823 Org: User:
Start: 03/24/23 End: 04/18/24 Due: 04/18/25

A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00732875 Org: User:
Start: 08/31/06 End: 05/31/08 Due: 05/31/09

A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)

Phase: N/A Priority: Normal
NCT ID: NCT01609231 Org: User:
Start: 07/06/12 End: 12/09/14 Due: 12/09/15